OTC artificial tears and antihistamines are a bandage. Rx-strength drops do the real work.
Scroll to Discover
Prescribed by U.S.-licensed providers and shipped discreetly to your door.
Allergic conjunctivitis (itchy, red, tearing) and chronic dry-eye disease (gritty, burning, blurry) are two completely different mechanisms — we cover both.
Once-daily prescription-strength H1-antihistamine + mast-cell stabilizer for allergic conjunctivitis — the watery, itchy, red-eye kind that OTC drops barely touch.
Twice-daily topical calcineurin inhibitor that quiets the T-cell-driven ocular surface inflammation behind chronic dry-eye disease. Generic for Restasis®. Takes 3–6 months to hit full effect — worth the wait.
LFA-1 / ICAM-1 integrin antagonist that blocks the T-cell activation driving ocular inflammation. Twice-daily Rx drop with faster onset than cyclosporine — symptoms often shift within 6 weeks.
Compounded dehydroepiandrosterone drops for severe dry eye disease (DED) and meibomian gland dysfunction (MGD) — particularly in post-menopausal women and in patients (of either sex) with documented sex-hormone deficiency. DHEA is a precursor to both androgens and estrogens at the ocular surface; lacrimal and meibomian glands carry the enzymes to convert it locally.
Compounded by 503A state-licensed pharmacies; not FDA-approved as a finished drug. Small single-center cohorts (e.g., Nakamura/Pflugfelder group, Schirmer-test improvements in post-menopausal refractory DED) suggest benefit; larger RCTs are lacking. Off-label only, typically after a documented trial of cyclosporine and/or lifitegrast. Provider reviews hormone-sensitive malignancy history, pregnancy status, and current HRT before prescribing.
Compounded topical testosterone for meibomian gland dysfunction (MGD) and evaporative dry eye — androgen receptors densely populate the meibomian and lacrimal glands, and age-related androgen decline is a known contributor to tear-film lipid-layer failure. Most useful when the dry-eye phenotype is evaporative (fast tear break-up time, reduced lipid meibum) rather than purely aqueous-deficient.
Compounded by 503A state-licensed pharmacies; not FDA-approved. Mechanistic foundation: Sullivan DA et al. (Schepens Eye Research Institute) — the androgen-MGD axis literature. Systemic absorption at ophthalmic doses is minimal but not zero — provider screens for prostate cancer (men), hormone-sensitive malignancy, pregnancy, and competitive-athlete status (trace serum elevation could affect anti-doping testing) before prescribing.
More eye-care options on the roadmap: perfluorohexyloctane (Miebo®) for evaporative dry eye, varenicline nasal spray (Tyrvaya®) for the neural-tear-production pathway, and ketotifen 0.025% for mild allergy. Your provider can order off-catalog through the patient portal.
The symptoms overlap — "my eyes are red and itchy and watery" could be either — but the treatments are completely different. Your provider asks a handful of differentiating questions at intake to pick the right path.
Seasonal pattern, sneezing, pet/pollen triggers, both eyes itch equally. → Olopatadine.
Screen-reading worse, gritty/burning, symptoms worse late in day, mild vision fluctuation. → Cyclosporine or Lifitegrast.
Quite common. Your provider can stack a non-preserved artificial tear under the Rx drop schedule.
Most drops require 15-min lens-off window. Preservative choice matters — we pick formulations that are contact-friendly where possible.
For mild seasonal itch, yes. For persistent symptoms, Rx-strength olopatadine (0.2% vs 0.1%) does more work per drop and gets you once-daily dosing. Visine-type "redness removers" are actually counter-productive for dry eye — they mask symptoms while worsening the underlying vasoconstriction.
It doesn't just stimulate tears — it reprograms the immune cells on your ocular surface. That takes weeks. Lifitegrast is faster because it blocks the downstream step (T-cell activation at ICAM-1) directly.
Preservative-containing drops: remove lenses, dose, wait 15 min, reinsert. Preservative-free unit doses (e.g., cyclosporine 0.05% PF): can be dosed with lenses in for many patients. Your provider will clarify for the exact product shipped.
Message your provider through the patient portal. Common next steps: add a meibomian-gland-focused therapy (warm compresses + topical azithromycin), switch between cyclosporine and lifitegrast, or refer out to ophthalmology if there's a mechanical or infectious cause we're missing.
Take 3 minutes and we'll match your symptom pattern to the right Rx.
Start my visit By continuing you agree to our Terms of Service.